Realcan Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 69.9% in First Half of 2023

Realcan Pharmaceutical Group Co.,Ltd. (瑞康医药集团股份有限公司) (002589.SZ) reported a net profit of 41.6 million yuan in the first half of 2023, down 69.9% year-on-year.

Meanwhile, the company posted 4.1 billion yuan in revenue, down 46% year-on-year.

At the end of the reporting period, it had 18.3 billion yuan in total assets and 12.5 billion yuan in total liabilities, with a liability-to-asset ratio of 68.3%.